Episode
S13E3: Creating Longevity Drugs for Dogs with Celine Halioua, Founder of Loyal
- Podcast
- The Room Podcast
- Published
- Oct 14, 2025
- Duration seconds
- 2678
- Processing state
not_requested- Canonical source
- https://the-room.castos.com
Actions
POST https://stenobird.com/v1/public/podcasts/the-room-podcast-3398569/episodes/s13e3-creating-longevity-drugs-for-dogs-with-celine-halioua-founder-of-loyal/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-room-podcast-3398569/s13e3-creating-longevity-drugs-for-dogs-with-celine-halioua-founder-of-loyal.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Welcome back to another episode of The Room Podcast! This week, we sit down with Celine Halioua, Founder and CEO of Loyal, a biotech company pioneering FDA-approved longevity drugs for dogs. From a childhood surrounded by rescue animals to an academic journey through neuroscience, health economics, and venture capital, Celine’s path to entrepreneurship is as winding as it is inspiring. Today, Loyal is leading the charge in redefining what’s possible in veterinary medicine—aiming not just to treat disease, but to extend healthy lifespan itself. In this episode, Celine shares how her scientific curiosity about aging and her love for animals converged into a singular mission. She takes us behind the scenes on the founding story of Loyal—from a chance conversation around a campfire, to navigating the capital-intensive world of biotech, to winning over regulators and pet parents alike. Listeners will walk away with hard-earned insights about fundraising in uncertain markets, balancing ambition with operational discipline, and the importance of being both scientifically rigorous and soulfully driven when building something truly generational.